a month ago
XENE
AnalystsTessa RomeroTessa Romero's Stock Forecasts
AnalystsTessa Romero
Sectors:
Industries:
Analyst Ranking
Top 13%
#670 out of 5153 analysts
Average Return
+20.84%
Win Rate
49%28 out of 57
Risk vs Reward
Poor
Good
Tessa Romero's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | +397.74% | $7.07 | $35.19 | 2024-10-02 - 2025-10-02 | Strong Buy |
Dyne Therapeutics IncDYN | +307.09% | $10.58 | $43.07 | 2023-08-08 - 2024-08-08 | Strong Buy |
Lexeo Therapeutics IncLXEO | +258.82% | $2.72 | $9.76 | 2025-05-29 - 2025-12-15 | Strong Buy |
Biohaven LtdBHVN | +174.33% | $14.65 | $40.19 | 2023-01-03 - 2024-01-03 | Strong Buy |
Edgewise Therapeutics IncEWTX | +132.39% | $7.75 | $18.01 | 2023-06-29 - 2024-06-28 | Strong Buy |
Tessa Romero Analyst Color
Get additional color on Tessa Romero's coverage of popular stocks
a month ago
SRRK
a month ago
EWTX
a year ago
BHVN
a year ago
CYTK
2 years ago
BHVN
Tessa Romero's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Agios Pharmaceuticals IncAGIO | 7 | Hold | $20.00 | -25.51% | Maintains | 25 days ago |
Biohaven LtdBHVN | 8 | Strong Buy | $15.00 | +32.98% | Maintains | a month ago |
Xenon Pharmaceuticals IncXENE | 3 | Strong Buy | $60.00 | +37.61% | Maintains | a month ago |
Scholar Rock Holding CorpSRRK | 5 | Strong Buy | $47.00 | +3.89% | Maintains | a month ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Sell | $263.00 | +7,612.61% | Downgrades | a month ago |
Acadia Pharmaceuticals IncACAD | 11 | Strong Buy | $31.00 | +13.72% | Maintains | a month ago |
Dyne Therapeutics IncDYN | 7 | Hold | $17.00 | -13.22% | Maintains | a month ago |
Edgewise Therapeutics IncEWTX | 10 | Strong Buy | $34.00 | +42.02% | Maintains | a month ago |
Cytokinetics IncCYTK | 5 | Strong Buy | $53.00 | -14.74% | Maintains | 6 months ago |
Lexeo Therapeutics IncLXEO | 2 | Strong Buy | $10.00 | +2.46% | Maintains | 7 months ago |
Upstream Bio IncUPB | 1 | Strong Buy | $38.00 | N/A | Initiates Coverage On | a year ago |
Neumora Therapeutics IncNMRA | 4 | Hold | $15.00 | N/A | Downgrades | a year ago |
Eyepoint Pharmaceuticals IncEYPT | 3 | Strong Buy | $29.00 | N/A | Maintains | a year ago |
Y Mabs Therapeutics IncYMAB | 5 | Strong Sell | $7.00 | N/A | Maintains | 2 years ago |
Seres Therapeutics IncMCRB | 1 | Hold | $140.00 | N/A | Initiates Coverage On | 3 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | $36.00 | N/A | Maintains | 3 years ago |
Orchard Therapeutics PLCORTX | 1 | Strong Buy | $150.00 | N/A | Assumes | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.